| Literature DB >> 26702410 |
Shekhar K Gadkaree1, Daniel Q Sun1, Jin Huang2, Ravi Varadhan3, Yuri Agrawal1.
Abstract
OBJECTIVE: To compare the predictive ability of standard falls prediction models based on physical performance assessments with more parsimonious prediction models based on self-reported data.Entities:
Keywords: Falls; fall risk; recurrent falls
Year: 2015 PMID: 26702410 PMCID: PMC4686273 DOI: 10.1177/2333721415584850
Source DB: PubMed Journal: Gerontol Geriatr Med ISSN: 2333-7214
Design of Tiered Prediction Models for Falls and Recurrent Falls.
| Model | Independent variables |
|---|---|
| Tier 1 | Age, gender, race |
| Tier 2 | Tier 1 + self-reported balance problem, history of fall |
| Tier 3 | Tier 2 + medical conditions[ |
| Tier 4 | Tier 3 + SPPB score[ |
Note. SPPB = Short Physical Performance Battery; NHATS = National Health and Aging Trends Study.
Heart attack, heart disease, stroke, hypertension, diabetes, osteoporosis, vision impairment, and hearing impairment.
Summary score of performance on side-by-side, semi-tandem, and full-tandem stances, chair stands, and gait speed (Kasper & Freedman, 2014) using NHATS percentiles.
Baseline Clinical Characteristics of Round 1 Community-Dwelling NHATS Participants and Stratified by Fall Outcome.
| NHATS ( | Any fall ( | Recurrent falls ( | |||
|---|---|---|---|---|---|
| Characteristic | % [95% CI][ | % [95% CI][ | % [95% CI][ | ||
| Overall | 32.9 [31.6, 34.3] | 15.0 [14.1, 15.9] | |||
| Demographics | |||||
| Gender | |||||
| Male | 43.4 [42.0, 44.8] | 30.0 [28.0, 32.7][ | <.001 | 14.7 [13.4, 16.1][ | .62 |
| Female | 56.6 [55.2, 58.0] | 35.2 [33.3, 37.0] | 15.2 [13.9, 16.6] | ||
| Age | |||||
| 65-69 | 27.9 [27.0, 29.0] | 29.6 [26.8, 32.5] | <.001 | 12.9 [11.2, 15.0] | <.001 |
| 70-74 | 25.0 [24.1, 25.8] | 28.7 [26.0, 31.5] | 12.5 [10.9, 14.3] | ||
| 75-79 | 19.1 [18.2, 19.9] | 33.4 [30.2, 36.7] | 13.1 [11.0, 15.6] | ||
| 80-84 | 14.7 [14.0, 15.4] | 37.5 [35.1, 40.1] | 18.0 [15.5, 20.7] | ||
| 85-89 | 9.1 [8.5, 9.8] | 42.4 [38.2, 46.8] | 23.6 [20.7, 26.8] | ||
| 90+ | 4.3 [3.8, 4.7] | 43.6 [38.6, 48.7] | 24.6 [20.7, 29.0] | ||
| Race/ethnicity | |||||
| NH White | 81.5 [79.7, 83.1] | 33.8 [32.3, 35.4] | <.001 | 15.5 [14.4, 16.6] | <.001 |
| NH Black | 8.2 [7.4, 9.1] | 27.1 [24.2, 30.2] | 12.3 [10.6, 14.2] | ||
| Other | 3.5 [2.8, 4.5] | 21.6 [15.2, 29.9] | 5.4 [3.1, 9.2] | ||
| Hispanic | 6.8 [5.8, 7.9] | 34.7 [29.5, 40.2] | 16.9 [13.7, 20.1] | ||
| Medical | |||||
| Self-reported problems with balance/coordination | |||||
| Yes | 28.2 [26.8, 29.5] | 51.7 [48.8, 54.6] | <.001 | 31.3 [28.8, 34.0] | <.001 |
| No | 71.8 [70.5, 73.2] | 48.3 [45.4, 51.2] | 9.0 [7.9, 10.1] | ||
| History of falls[ | |||||
| Yes | 30.5 [29.4, 31.6] | 50.7 [47.5, 53.9] | <.001 | 26.5 [23.7, 29.4] | <.001 |
| No | 69.5 [68.4, 70.6] | 23.3 [21.8, 24.9] | 7.4 [6.5, 8.3] | ||
| Conditions | |||||
| Heart attack | |||||
| Yes | 14.1 [13.1, 15.1] | 42.5 [37.8, 47.2] | <.001 | 20.1 [17.9, 24.5] | <.001 |
| No | 85.9 [84.9, 86.9] | 31.4 [30.0, 32.8] | 14 [13.1, 15.0] | ||
| Heart disease | |||||
| Yes | 17.5 [16.5, 18.5] | 42.3 [39.2, 45.6] | <.001 | 21.7 [19.5, 24.1] | <.001 |
| No | 82.6 [81.5, 83.5] | 31.0 [29.6, 32.4] | 13.6 [12.6, 14.6] | ||
| Stroke | |||||
| Yes | 10.0 [9.3, 10.9] | 49.5 [44.6, 54.4] | <.001 | 26.0 [22.0, 30.4] | <.001 |
| No | 90.0 [89.2, 90.7] | 31.1 [29.8, 32.5] | 13.8 [12.8, 14.8] | ||
| Diabetes | |||||
| Yes | 23.9 [22.7, 25.1] | 37.5 [35.0, 40.2] | <.001 | 19.5 [17.2, 21.9] | <.001 |
| No | 76.1 [74.9, 77.3] | 31.5 [29.9, 33.1] | 13.6 [12.6, 14.6] | ||
| Hypertension | |||||
| Yes | 63.9 [62.5, 65.3] | 34.7 [32.9, 36.6] | .001 | 16.1 [14.9, 17.4] | .005 |
| No | 36.1 [34.7, 37.5] | 29.7 [27.6, 31.8] | 12.9 [11.4, 14.5] | ||
| Osteoporosis | |||||
| Yes | 21.2 [20.2, 22.2] | 41.1 [37.7, 44.7] | <.001 | 20.1 [17.7, 22.8] | <.001 |
| No | 78.8 [77.8, 79.8] | 30.7 [29.2, 32.3] | 13.6 [12.6, 14.7] | ||
| Vision | |||||
| Normal | 38.4 [37.2, 39.7] | 32.0 [29.5, 34.7] | .24 | 14.5 [12.7, 16.6] | .004 |
| Corrective lenses | 61.1 [59.9, 62.4] | 33.3 [31.6, 35.0] | 14.9 [13.9, 16.0] | ||
| Blind | 0.43 [0.31, 0.59] | 47.4 [31.8, 63.6] | 41.0 [24.9, 59.3] | ||
| Hearing | |||||
| Normal | 88.1 [87.2, 88.9] | 32.4 [31.0, 33.8] | .090 | 14.5 [13.5, 15.5] | .121 |
| Hearing aides | 11.7 [10.8, 12.6] | 36.6 [33.2, 40.0] | 17.9 [15.0, 21.3] | ||
| Deaf | 0.2 [0.1, 0.4] | 30.5 [11.3, 60.1] | 18.4 [4.0, 55.0] | ||
| Physical performance testing | |||||
| Gait speed[ | |||||
| 0 | 9.0 [8.1, 9.9] | 47.4 [43.4, 51.4] | <.001 | 26.5 [22.6, 30.8] | <.001 |
| 1 | 11.0 [10.0, 12.1] | 42.4 [39.4, 45.5] | 23.2 [20.9, 25.8] | ||
| 2 | 17.1 [15.9, 18.3] | 32.8 [29.7, 36.2] | 14.2 [11.9, 16.7] | ||
| 3 | 24.9 [23.7, 26.1] | 27.5 [24.4, 30.8] | 10.3 [8.5, 12.4] | ||
| 4 | 38.1 [36.2, 39.9] | 23.7 [20.2, 27.6] | 8.4 [6.6, 10.8] | ||
| SPPB score[ | |||||
| 0 | 7.3 [6.5, 8.2] | 46.8 [41.5, 52.2] | <.001 | 27.5 [22.5, 33.2] | <.001 |
| 1 | 1.9 [1.7, 2.2] | 58.4 [47.9, 68.2] | 34.6 [25.2, 45.4] | ||
| 2 | 2.7 [2.3, 3.2] | 50.9 [45.5, 56.2] | 28.4 [23.6, 33.7] | ||
| 3 | 2.9 [2.6, 3.3] | 45.6 [39.6, 51.7] | 27.3 [22.0, 33.3] | ||
| 4 | 3.1 [2.7, 3.6] | 36.2 [30.1, 42.8] | 15.5 [11.5, 20.5] | ||
| 5 | 3.6 [3.1, 4.1] | 41.8 [37.0, 46.8] | 20.8 [17.4, 24.8] | ||
| 6 | 4.7 [4.1, 5.4] | 34.3 [28.7, 40.4] | 15.6 [11.6, 20.7] | ||
| 7 | 5.9 [5.3, 6.6] | 32.3 [27.2, 37.8] | 12.3 [9.5, 15.8] | ||
| 8 | 8.0 [7.2, 8.9] | 27.5 [22.3, 33.3] | 9.5 [6.7, 13.4] | ||
| 9 | 9.8 [9.1, 10.5] | 20.0 [16.9, 23.6] | 6.5 [4.6, 9.1] | ||
| 10 | 12.7 [11.7, 13.7] | 21.0 [16.9, 25.7] | 8.3 [5.7, 12.0] | ||
| 11 | 16.7 [15.5, 18.1] | 28.8 [23.0, 35.5] | 9.2 [6.1, 13.7] | ||
| 12 | 20.7 [19.4, 22.1] | 19.1 [13.3, 26.5] | 7.5 [5.9, 9.5] | ||
Note. NHATS = National Health and Aging Trends Study; CI = confidence interval; NH = non-Hispanic; SPPB = Short Physical Performance Battery.
Weighted frequency, since Round 1 interview.
Pearson’s chi-square.
Row percentages were used for analysis. For example, 30.0% of Round 1 NHATS males experienced “any fall” and 14.7% experienced “recurrent falls.”
History of falls were assessed at the onset of NHATS Round 1 interviews and defined as having fallen in the preceding 12 months.
Gait speed was assessed using fastest time taken for participant to walk 3 m from two trials. This velocity was stratified into quartiles for the NHATS population, with 0 indicating the test was not completed or attempted; and 1 to 4 corresponding to increasing quartiles of performance, with a score of 4 representing best performances.
SPPB testing was assessed through the three domains of balance testing (side-by-side, semi-tandem, full-tandem), walking speed, and repeated chair stands. Walking speed and repeated chair stands were scored according to increasing quartiles of performance, with 0 indicating the test was not completed or attempted, and 1 to 4 corresponding to increasing quartiles of performance. Balance testing was scored as follows: 0 (tests were not attempted); 1 (completion of only side-by-side testing without completion of semi-tandem testing); 2 (completion of semi-tandem testing and either not attempting or holding full-tandem for less than 2.99 s); 3 (completion of semi-tandem testing and holding full-tandem from between 3 s to 9.99 s); 4 (completion of full-tandem testing). Completion of a balance stance required holding that stance for 10 s.
Figure 1.Risk models for the prediction of falls and recurrent falls using development set data.
Note. AUC comparison for progressive model tiers for falls and recurrent falls in the development set population (two thirds of overall NHATS population, n = 5,070). AUC = area under curve; NHATS = National Health and Aging Trends Study.
aConfidence interval.
AppendixRisk model for the prediction of falls and recurrent falls from Tier 2 model using training data.
Note. Age range of 65 to 69, male gender, and White race were used as reference categories (OR = 1.0) for age, gender, and race, respectively. SE = standard error; OR = odds ratio; CI = confidence Interval.
*p < .05. **p < .01. ***p < .001.
Figure 2.Tier 2 model ROC curves and AUC in validation set.
Note. ROC curves, and their respective AUC for the Tier 2 model validated in the one third of the overall study population (n = 2,539) not included in the model development population (n = 5,070). ROC curve for model development population (black) and validation population (red) are shown. ROC = receiver operator characteristic.
aArea under curve.
bConfidence Interval.